Shanghai IxCell Biotech Co., ∞×Ltd. is a biotechnology company speβ™$Ωcializing in cell-based pharmace↔β®uticals, with advanced capabiφ↑±lities in large-scale≥ ≠ manufacturing for cell the±σrapies. Our mission, "Ded ¶ icated to unmatched ex♦☆±cellence in the advancement of c‍δell-based pharmaceuticals," dr↓₹♥∏ives us to develop a robust product®₹ pipeline in three primary are©→‌as: mesenchymal stem cell therapies, in♠‌‌duced pluripotent st₽×em cell therapies, and immune≤≈∞ cell therapies, all support¥σed by a state-of-the-art manufac$σturing platform. OurΩ" clinical pipeline targσ→∞ets a range of disea↕♣<↔ses, including knee osteoarthritis,γ ≤  stroke, pulmonary fibrosis, autoimmun"​∞e disorders, and solid tumors. Th σ×rough independent research and c™₩★×ontinuous innovation, weΩ←φ☆ have secured over forty patentσ∏₹s for cell therapy inventioσ★εns and set industry-leading manufac©↑λturing standards. Our 4,000-square-mδ÷₽eter facility in the Zhangjiang Co£↕φre Park of Pudong, Shanghai, int€δ✘₹egrates research, development, and pro♥φ≈duction, allowing for seamle$♦→♦ss transition from discovery t ≈$​o commercialization.